| Ticker: | OKYO |
| Current Price: | $1.35 |
| % Daily Change: | -3.57% |
| Volume (1,000s): | 264.10 |
| Average Volume (1,000s): | 94.55 |
| Market Cap (M): | $70.85 |
| 1/2/2024 Price: | $1.94 |
| Change Since Inception: | -30.41% |
OKYO Pharma Limited
Head Office – USA
420 Lexington Avenue
Suite 1402
New York, NY 10170
OKYO Pharma focuses on:
A novel class of membrane-anchored Chemerin receptor GPCR agonist that targets the inflammatory pathways to treat dry eye syndrome, uveitis and allergic conjunctivitis.
An agonist for MAS-Related G Protein-Coupled Receptor (MRGPR), a non-opioid analgesic, for ocular and chronic pain management using novel topical and nasal formulations.